-
Hong Kong Special Administrative Region Government: The kosing vaccine is approved for emergency use in accordance with regulations
Time of Update: 2021-02-24
THE SAR Government means that the advisory committee's examination of the data and the Government's approval process is rigorous, comprehensive and meets the relevant requirements under all the Regulations, which is no different from the procedure for approving the previous new crown vaccine approved for emergency use in Hong Kong.
-
Heavy! The State Council issued a good document on the interests of Chinese medicine and respected the law of research and development of Chinese medicine
Time of Update: 2021-02-24
(The State Administration of Traditional Chinese Medicine, the National Development and Reform Commission, the National Health And Health Commission, the Ministry of Industry and Information Technology, the State Drug Administration is responsible for) to improve the Western medicine study of Chinese medicine system from 2021, the Chinese medicine curriculum as a compulsory undergraduate clinical medicine major and graduation internship content, increase the course time.
-
From drug-free to multiple treatments, 34 clinically urgently needed new drugs have been approved
Time of Update: 2021-02-24
addition, NMPA has approved a number of clinically urgent overseas drugs to bring innovative therapies to patients with multiple types of diseases.
-
General Administration of Market Supervision: Third-party nucleic acid testing institutions may not use service packages and other means to force bundle charges
Time of Update: 2021-02-24
Pharmaceutical Network February 8th, February 7th, the General Office of the General Administration of Market Supervision announced the "Notice on doing a good job in the near-term price supervision c
-
The State Drug Administration identified the second batch of 72 key laboratories, such as in-body diagnostic reagent quality research and evaluation
Time of Update: 2021-02-24
February 2021, the State Drug Administration identified and announced the second batch of 72 key laboratories, such as in-body diagnostic reagent quality research and evaluation.
, improving the drug regulatory authority's ability to respond to major public health emergencies has become an important consideration in the comprehensive evaluation.
-
Drug enterprise risk warning issued 33 pharmaceutical companies on the list!
Time of Update: 2021-02-24
2, Shandong Weizhi Encycloddic Pharmaceutical Co., Ltd. the company produced hydrochloric acid Lidokain injection, "check" item "visible foreign body" does not meet the standard provisions, Shandong Provincial Drug Administration issued a decision on administrative punishment, fined about 495,000 yuan.
-
Guangxi Medical Complex: Unified procurement of pharmaceutical supplies unified payment
Time of Update: 2021-02-24
Unified procurement unified payment, the basic medical device procurement model changes "notice" first clearly, the current measures referred to as the medical association including but not limited to urban medical groups, county medical and health community (hereinafter referred to as county medical community), three-two medical associations, specialized alliances and telemedicanic collaboration network.
-
Baiji Shenzhou BTK inhibitor Zebutini new adaptive disease listing application was accepted by the FDA
Time of Update: 2021-02-24
On February 17, Baiji Shenzhou announced that the U.S. FDA had accepted a new application (SNDA) for the treatment of patients with Fahrenheit globulinemia (WM), with the PDUFA dated October 18, 2021.
-
The State Drug Administration revised the six-flavored yellow preparation instruction manual
Time of Update: 2021-02-24
Annex Annex 2 Revised requirements for over-the-counter prescription drugs for six-flavored yellow preparations Should include: Monitoring data show that six-flavored yellow preparations have diarrhea, abdominal pain, bloating, nausea, vomiting, gastrointestinal discomfort, loss of appetite, constipation, itching, rash, headache, palpitations, allergies and other adverse reactions reported.
-
Six-flavored yellow pill modification instruction manual Adverse reactions increased by 13 items
Time of Update: 2021-02-24
It is cold and greasy, can not eat a lot of people Zhu Xinyi told Yangzi Evening News reporter, taking six-flavored yellow preparations, the most common adverse reaction is the symptoms of the digestive tract, mainly because the six-flavored yellow pills belong to the cold medicine, at the same time it is a complementary drug, so it is greasy.
-
Volunteers "testing drugs on their es"? The United States has approved human trials of the new coronavirus
Time of Update: 2021-02-24
At that time, 90 adult volunteers between the ages of 18 and 30 will be exposed to the new coronavirus in a safe and controlled environment to help researchers understand how the human body responds to the virus, how it spreads, and the minimum number of viruses needed to cause infection.
-
Price reduction of 80%, such medical devices only 3.6 yuan
Time of Update: 2021-02-24
Pharmaceutical Network February 18, an average drop of 80% recently, according to the Hunan Provincial Health Insurance Bureau, from February 10, Hunan Province officially implemented the new coronavirus nucleic acid testing related medical supplies centralized procurement results.
-
The study revealed the exact cause of death of a python in ancient Egypt 3,600 years ago
Time of Update: 2021-02-24
CAIRO, Feb. 17 (Xinhua Wu Dani Marwa Yahya) Egyptian archaeologists and medical experts published a study on the 17th showed that about 3,600 years ago, the ancient Egyptian 17th Dynasty python Segenenla should have been killed in the battle with the Hexos, whose head wounds were cleverly hidden by mummy makers.
-
The official briefing is coming! The State Drug Administration disclosed the latest progress in the development of the new crown vaccine
Time of Update: 2021-02-24
Pharma Network February 19 - February 19, the Supreme People's Procuratorate, the State Administration of Market Supervision and Administration and the State Drug Administration, jointly issued 15 imp
-
Pharmaceutical companies' China revenue, Top7 announced (with list)
Time of Update: 2021-02-24
According to The Rubik's Cube, seven foreign pharmaceutical companies that announced China's performance will achieve a total of $21.4 billion in 2020, of which AstraZeneta continues to rank first in the Chinese market for multinational pharmaceutical companies with nearly $5.4 billion in Chinese revenue, with Merca East and Roche in second and third place respectively.
-
The limit is approaching 44 large varieties from August 1st to transfer a local health insurance
Time of Update: 2021-02-24
Medical network February 20th, the big limit approaching, local medical insurance transfer work continues, 44 large varieties from August 1st transferred out of a local medical insurance catalog 44 la
-
New technology pulls out 'silent killer' in tumor stem cells
Time of Update: 2021-02-24
Surprisingly, these tumor stem cells are usually in a resting state, with low telomerase activity and the ability to maintain relatively short telomere lengths due to their non-proliferation.
-
State Drug Administration: The six-flavored yellow preparation instructions for a unified revision
Time of Update: 2021-02-24
the announcement stressed that the provincial drug supervision and administration departments should urge the drug market license holders of the above-mentioned drugs in the administrative area to do a good job in accordance with the requirements of the corresponding manual revision and labeling, manual replacement work, the violation of the law and strict investigation and punishment.
-
The six-flavored yellow instruction manual was changed to affect more than 500 pharmaceutical companies
Time of Update: 2021-02-24
Six-flavored yellow preparation over-the-counter prescription drug instructions revised requirements: First, the "adverse reactions" item should include: monitoring data show that hexa-yellow preparations have diarrhea, abdominal pain, bloating, nausea, vomiting, gastrointestinal discomfort, loss of appetite, constipation, itching, rash, headache, palpitations, allergies and other adverse reactions reported.
-
Maximum drop of 96.24%! 113 injection belt volume procurement selected
Time of Update: 2021-02-24
Pharmaceutical Network February 19th, Wuhan Pharmaceuticals Joint Procurement Office announced the first batch of drugs in Hubei Province centralized band procurement results, 29 injection varieties all successfully purchased, a total of 113 drugs selected.
